FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313622221> ?p ?o ?g. }

• W4313622221 endingPage "1160" @default.
• W4313622221 startingPage "1153" @default.
• W4313622221 abstract "Immunogenicity and safety up to 5 years after administration of 1 or 2 doses of quadrivalent meningococcal serogroup A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT) given alone or with 13-valent pneumococcal conjugate vaccine (PCV13) in children was investigated. This phase 3 study randomized healthy 12–24-month-olds to MenACWY-TT at Month 0 (ACWY1d), MenACWY-TT at Months 0 and 2 (ACWY2d), MenACWY-TT and PCV13 at Month 0 (Co-Ad), or PCV13 at Month 0 and MenACWY-TT at Month 2 (PCV13/ACWY). Immune responses 1, 3, and 5 years after primary vaccination were evaluated with serum bactericidal activity using rabbit complement (rSBA) titers ≥ 1:8 and geometric mean titers (GMTs). Evaluation of serious adverse events up to 5 years after primary vaccination are reported. Of the 802 children randomized in the study, 619 completed the study through Year 5. Immune responses after vaccination declined over time but were higher 5 years after vaccination compared with levels before vaccination. At Year 5, the percentages of children with rSBA titers ≥ 1:8 across all serogroups were 20.5 %−58.6 %, 28.4 %−65.8 %, 23.9 %−52.8 %, and 19.4 %−55.8 % in the ACWY1d, ACWY2d, Co-Ad, and PCV13/ACWY groups, respectively. Comparable antibody persistence at Year 5 was observed for participants receiving 1 or 2 doses of MenACWY-TT, although GMTs were elevated in those who received 2 versus 1 dose. The percentage of children with protective antibody titers at Year 5 was similar in participants who received PCV13 and MenACWY-TT compared with that observed for participants who only received 1 or 2 MenACWY-TT doses. No new safety concerns were identified during the study period. Antibody responses persisted in the majority of children up to 5 years after primary vaccination with MenACWY-TT administered in a 1- or 2-dose regimen with or without PCV13, with no new safety concerns identified. ClinicalTrials.gov Identifier NCT01939158; EudraCT number 2013–001083-28." @default.
• W4313622221 created "2023-01-07" @default.
• W4313622221 creator A5004835326 @default.
• W4313622221 creator A5025483944 @default.
• W4313622221 creator A5034115310 @default.
• W4313622221 creator A5040150475 @default.
• W4313622221 creator A5042404549 @default.
• W4313622221 creator A5078145335 @default.
• W4313622221 date "2023-01-01" @default.
• W4313622221 modified "2023-09-26" @default.
• W4313622221 title "A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12–14-month-old children" @default.
• W4313622221 cites W1993196671 @default.
• W4313622221 cites W2115350923 @default.
• W4313622221 cites W2167184183 @default.
• W4313622221 cites W2301673964 @default.
• W4313622221 cites W2323071065 @default.
• W4313622221 cites W2332840432 @default.
• W4313622221 cites W2793849706 @default.
• W4313622221 cites W2896525071 @default.
• W4313622221 cites W2898577694 @default.
• W4313622221 cites W2921426677 @default.
• W4313622221 cites W2947842971 @default.
• W4313622221 cites W3016945681 @default.
• W4313622221 cites W3024264817 @default.
• W4313622221 cites W3035876477 @default.
• W4313622221 cites W3040402247 @default.
• W4313622221 cites W3186896088 @default.
• W4313622221 cites W3203383468 @default.
• W4313622221 doi "https://doi.org/10.1016/j.vaccine.2022.11.048" @default.
• W4313622221 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36621408" @default.
• W4313622221 hasPublicationYear "2023" @default.
• W4313622221 type Work @default.
• W4313622221 citedByCount "0" @default.
• W4313622221 crossrefType "journal-article" @default.
• W4313622221 hasAuthorship W4313622221A5004835326 @default.
• W4313622221 hasAuthorship W4313622221A5025483944 @default.
• W4313622221 hasAuthorship W4313622221A5034115310 @default.
• W4313622221 hasAuthorship W4313622221A5040150475 @default.
• W4313622221 hasAuthorship W4313622221A5042404549 @default.
• W4313622221 hasAuthorship W4313622221A5078145335 @default.
• W4313622221 hasConcept C126322002 @default.
• W4313622221 hasConcept C159654299 @default.
• W4313622221 hasConcept C168563851 @default.
• W4313622221 hasConcept C187212893 @default.
• W4313622221 hasConcept C197934379 @default.
• W4313622221 hasConcept C203014093 @default.
• W4313622221 hasConcept C22070199 @default.
• W4313622221 hasConcept C2777351567 @default.
• W4313622221 hasConcept C2778866548 @default.
• W4313622221 hasConcept C2779583294 @default.
• W4313622221 hasConcept C2779841045 @default.
• W4313622221 hasConcept C2780454893 @default.
• W4313622221 hasConcept C2780801004 @default.
• W4313622221 hasConcept C2780868878 @default.
• W4313622221 hasConcept C2781253189 @default.
• W4313622221 hasConcept C32611913 @default.
• W4313622221 hasConcept C501593827 @default.
• W4313622221 hasConcept C71924100 @default.
• W4313622221 hasConcept C86803240 @default.
• W4313622221 hasConcept C89423630 @default.
• W4313622221 hasConceptScore W4313622221C126322002 @default.
• W4313622221 hasConceptScore W4313622221C159654299 @default.
• W4313622221 hasConceptScore W4313622221C168563851 @default.
• W4313622221 hasConceptScore W4313622221C187212893 @default.
• W4313622221 hasConceptScore W4313622221C197934379 @default.
• W4313622221 hasConceptScore W4313622221C203014093 @default.
• W4313622221 hasConceptScore W4313622221C22070199 @default.
• W4313622221 hasConceptScore W4313622221C2777351567 @default.
• W4313622221 hasConceptScore W4313622221C2778866548 @default.
• W4313622221 hasConceptScore W4313622221C2779583294 @default.
• W4313622221 hasConceptScore W4313622221C2779841045 @default.
• W4313622221 hasConceptScore W4313622221C2780454893 @default.
• W4313622221 hasConceptScore W4313622221C2780801004 @default.
• W4313622221 hasConceptScore W4313622221C2780868878 @default.
• W4313622221 hasConceptScore W4313622221C2781253189 @default.
• W4313622221 hasConceptScore W4313622221C32611913 @default.
• W4313622221 hasConceptScore W4313622221C501593827 @default.
• W4313622221 hasConceptScore W4313622221C71924100 @default.
• W4313622221 hasConceptScore W4313622221C86803240 @default.
• W4313622221 hasConceptScore W4313622221C89423630 @default.
• W4313622221 hasFunder F4320307765 @default.
• W4313622221 hasIssue "5" @default.
• W4313622221 hasLocation W43136222211 @default.
• W4313622221 hasLocation W43136222212 @default.
• W4313622221 hasOpenAccess W4313622221 @default.
• W4313622221 hasPrimaryLocation W43136222211 @default.
• W4313622221 hasRelatedWork W1987029428 @default.
• W4313622221 hasRelatedWork W1993196671 @default.
• W4313622221 hasRelatedWork W2005063593 @default.
• W4313622221 hasRelatedWork W2039306904 @default.
• W4313622221 hasRelatedWork W2052401390 @default.
• W4313622221 hasRelatedWork W2064042755 @default.
• W4313622221 hasRelatedWork W2353634210 @default.
• W4313622221 hasRelatedWork W2981636029 @default.
• W4313622221 hasRelatedWork W3029354734 @default.
• W4313622221 hasRelatedWork W4291019507 @default.
• W4313622221 hasVolume "41" @default.
• W4313622221 isParatext "false" @default.

• next